Theraclion Strengthens Management Team With New CEO

Theraclion, a company specializing in medical equipment for echotherapy, has strengthened its management team by appointing David Caumartin to succeed Stefano Vagliani as CEO, and Anja Kleber as vice president of Marketing/Market Access.
 
Caumartin is a healthcare industry specialist with 14 years’ experience at GE Healthcare, covering Europe, Middle East and Africa and the United States working in sales, marketing and development of new products, scanners and conventional radiology. From 2007 to 2011 he was global head of mammography. In 2012, Caumartin joined Alstom Thermal Power as vice president responsible for M&A strategy. He is a graduate of Telecom Paris with a masters degree in fundamental physics from Paris Diderot University and he also is a certified Six Sigma Master Black Belt.
 
Kleber began her career in 2002 in the Siemens Medical marketing team. In 2006, she joined Accuray as head of Radiosurgery/Radiotherapy products. She was promoted to lead the company’s public affairs department in 2009 before being appointed head of Marketing/Market Access a year later. Kleber is an IT graduate of the University of Karlsruhe and did her thesis at INSA Lyon. She has dual French-German nationality.
 
“On behalf of all our teams, I would like to thank Stefano Vagliani for the direction he gave Theraclion during his time as CEO, and particularly for his contribution to setting up the company’s organization and procedures and his work during the flotation. The appointment of this new management team is a major step for Theraclion. The arrival of these new managers will allow us to drive forward the company’s commercial development and consolidate our presence in our target markets” said Jean-Yves Burel, board chairman.
 
Based in Malakoff (near Paris), France, Theraclion designs, develops and markets a medical device (Echopulse) that combines advanced ultrasound imaging and HIFU therapy. Theraclion is ISO 13485 certified and has received the CE mark for non-invasive ablation of breast fibroadenomas and thyroid nodules.